New combo pill for high cholesterol tested on thousands
NCT ID NCT06314919
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is testing a fixed-dose combination of two cholesterol-lowering drugs, pitavastatin and ezetimibe, in over 8,600 people with high cholesterol or mixed lipid disorders. The goal is to see how well the combo works and how safe it is in real-world conditions, outside of a strict research setting. Participants are already on statins or ezetimibe and are switching to the combo pill.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pitavastatin and Ezetimibe (fixed-dose combination)
What this could lead to
If successful, this could confirm that the fixed-dose combination is effective and safe for managing high cholesterol in everyday practice.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. It also focuses on cholesterol levels, not long-term health outcomes like heart attacks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ewha Womans University Seoul Hospital
RECRUITINGSeoul, South Korea
Contact